for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Drugmakers in spotlight as GSK recalls Zantac

Posted

Drugmakers were in the spotlight Wednesday as GSK recalls Zantac after U.S. regulators found probable cancer-causing impurities in the drug. Also in the U.S.: a jury says Johnson & Johnson must pay $8 billion in a case over male breast growth linked to Risperdal. David Pollard reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up